Cargando…

Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)

INTRODUCTION: Dyspnoea is common in patients with interstitial lung disease (ILD) and often refractory to conventional treatment. Little is known about the efficacy of systemic morphine for dyspnoea in patients with ILD. The aim of this study is to estimate the efficacy of a single subcutaneous morp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuda, Yoshinobu, Morita, Tatsuya, Oyamada, Shunsuke, Ariyoshi, Keisuke, Yamaguchi, Takuhiro, Iwase, Satoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130746/ https://www.ncbi.nlm.nih.gov/pubmed/34006542 http://dx.doi.org/10.1136/bmjopen-2020-043156

Ejemplares similares

Predictors of Morphine Efficacy for Dyspnea in Inpatients with Chronic Obstructive Pulmonary Disease: A Secondary Analysis of JORTC-PAL 07
por: Matsuda, Yoshinobu, et al.
Publicado: (2021)

Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09)
por: Iwase, Satoru, et al.
Publicado: (2015)

The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02)
por: Nishiyama, Nanako, et al.
Publicado: (2020)

Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol
por: Matsuoka, Hiromichi, et al.
Publicado: (2022)

Efficacy of oral administration of cystine and theanine in colorectal cancer patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03)
por: Hamaguchi, Reo, et al.
Publicado: (2019)

Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study
por: Matsuoka, Hiromichi, et al.
Publicado: (2017)

Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02)
por: Ohnishi, Shunsuke, et al.
Publicado: (2017)

A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103
por: Sadahiro, Ryoichi, et al.
Publicado: (2023)

Dyspnoea-12: a translation and linguistic validation study in a Swedish setting
por: Sundh, Josefin, et al.
Publicado: (2017)

Understanding changes in dyspnoea perception in obstructive lung disease after mindfulness training
por: Malpass, Alice, et al.
Publicado: (2018)

Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease
por: Sundh, Josefin, et al.
Publicado: (2019)

Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in ‘long COVID’ patients with persistent dyspnoea
por: Frésard, Isabelle, et al.
Publicado: (2022)

Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial
por: Hamaguchi, Reo, et al.
Publicado: (2018)

Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)
por: Cash, Elizabeth, et al.
Publicado: (2023)

How different are COPD-specific patient reported outcomes, health status, dyspnoea and respiratory symptoms? An observational study in a working population
por: Nishimura, Koichi, et al.
Publicado: (2019)

Microbial communities in the respiratory tract of patients with interstitial lung disease
por: Garzoni, Christian, et al.
Publicado: (2013)

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis
por: Nakashita, Tamao, et al.
Publicado: (2014)

Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features
por: Kamiya, Hiroyuki, et al.
Publicado: (2019)

Effectiveness of Morphine in Managing Refractory Dyspnoea in Patients with Coronavirus Disease (COVID-19)
por: Sirohiya, Prashant, et al.
Publicado: (2022)

A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia
por: Usui, Yutaka, et al.
Publicado: (2013)

Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults
por: Ioannides, Sally J, et al.
Publicado: (2014)

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study
por: Hozumi, Hironao, et al.
Publicado: (2013)

Systematic review and meta-analysis of prognostic factors for idiopathic inflammatory myopathy-associated interstitial lung disease
por: Kamiya, Hiroyuki, et al.
Publicado: (2018)

Comparison of statistical models for estimating intervention effects based on time-to-recurrent-event in stepped wedge cluster randomized trial using open cohort design
por: Oyamada, Shunsuke, et al.
Publicado: (2022)

Interstitial Lung Disease Associated Acute Respiratory Failure Requiring Invasive Mechanical Ventilation: A Retrospective Analysis
por: Vahdatpour, Cyrus A., et al.
Publicado: (2020)

Survey-identified experiences of prediagnosis and diagnosis process among patients with COPD, asthma, interstitial lung disease and bronchiectasis
por: Zhang, Xiubin, et al.
Publicado: (2023)

Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
por: Finney, Lydia J.
Publicado: (2019)

Prognostic factors of idiopathic inflammatory myopathies complicated with interstitial lung disease: protocol for a systematic review and meta-analysis
por: Kamiya, Hiroyuki, et al.
Publicado: (2016)

Features and predictive value of 6-min walk test outcomes in interstitial lung disease: an observation study using wearable monitors
por: Li, Jiaying, et al.
Publicado: (2022)

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
por: Hanania, Nicola A, et al.
Publicado: (2015)

Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation
por: Bourbeau, Jean, et al.
Publicado: (2016)

Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody
por: Kamiya, Hiroyuki, et al.
Publicado: (2021)

Effect of acetazolamide on obstructive sleep apnoea in highlanders: protocol for a randomised, placebo-controlled, double-blinded crossover trial
por: Tan, Lu, et al.
Publicado: (2022)

Comparison of high-intensity interval training versus moderate-intensity continuous training in pulmonary rehabilitation for interstitial lung disease: a randomised controlled pilot feasibility trial
por: Nikoletou, Dimitra, et al.
Publicado: (2023)

RCT of the effect of berryfruit polyphenolic cultivar extract in mild steroid-naive asthma: a cross-over, placebo-controlled study
por: Power, Sharon, et al.
Publicado: (2017)

Vitamin D in the prevention of exacerbations of asthma in preschoolers (DIVA): protocol for a multicentre randomised placebo-controlled triple-blind trial
por: Jensen, Megan E, et al.
Publicado: (2019)

Inhibition of bradykinin in SARS-CoV-2 infection: a randomised, double-blind trial of icatibant compared with placebo (ICASARS)
por: Bailey, Melanie, et al.
Publicado: (2023)

High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors
por: Dhoubhadel, Bhim Gopal, et al.
Publicado: (2022)

Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design
por: Troosters, Thierry, et al.
Publicado: (2016)

Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial
por: Lyu, Yee Ran, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v8mtjfs7mgun3ft8o8e1iveei4